Alkermes plc · , Dublin Ireland (NASDAQ: ALKS)
| Treasury Bldg. , Lower Grand Canal St, | Phone: +353-1-772-8000 |
| , Dublin | |
| Ireland | 
Map This Company |
Alkermes plc Rankings
Company Description
Alkermes is working some medicinal alchemy. The firm uses its proprietary drug-delivery systems to make compounds that require less frequent dosing or provide more targeted delivery. Focusing primarily on psychiatric medications, it has a couple of drugs on the market that use its injectable extended-release technology, which lets patients take a drug once or twice a month, rather than once or twice a day. One such drug is Risperdal Consta, a long-acting version of
Alkermes plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ALKS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 600 |
Executives
21 executives listed for Alkermes plc's, Dublin location.
| Chairman and CEO | Richard Pops | |
|---|---|---|
| President | Shane Cooke | |
| SVP, COO, and Chief Risk Officer | Gordon Pugh |